Topic: Genomics

The company plans to use the money to help expand its pipeline and scale. 

The engineered viruses used to deliver gene therapies can spark complications and they can’t be re-dosed. Ring Therapeutics says viruses that evolved with humans can be better viral vectors and the startup has raised $117 million in new financing to continue its research.

In the year and a half since its purchase by Illumina was thwarted by the […]

Glaucoma can cause blindness and has no cure, as current therapies only slow vision loss […]

Deep Genomics is wasting no time. Two weeks after hiring a new chief business officer […]